These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1113 related items for PubMed ID: 25467043

  • 21. Does AMH Reflect Follicle Number Similarly in Women with and without PCOS?
    Christiansen SC, Eilertsen TB, Vanky E, Carlsen SM.
    PLoS One; 2016; 11(1):e0146739. PubMed ID: 26799212
    [Abstract] [Full Text] [Related]

  • 22. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome.
    Shandley LM, Fothergill A, Spencer JB, Mertens AC, Cottrell HN, Howards PP.
    Fertil Steril; 2018 Mar; 109(3):516-525.e1. PubMed ID: 29428311
    [Abstract] [Full Text] [Related]

  • 23. Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes.
    Tal R, Seifer DB, Khanimov M, Malter HE, Grazi RV, Leader B.
    Am J Obstet Gynecol; 2014 Jul; 211(1):59.e1-8. PubMed ID: 24593938
    [Abstract] [Full Text] [Related]

  • 24. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS.
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [Abstract] [Full Text] [Related]

  • 25. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N, Pehlivanov B, Orbecova M, Uchikova E, Ivancheva H.
    Akush Ginekol (Sofiia); 2014 Jul; 53(5):22-7. PubMed ID: 25558667
    [Abstract] [Full Text] [Related]

  • 26. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.
    Wongwananuruk T, Panichyawat N, Indhavivadhana S, Rattanachaiyanont M, Angsuwathana S, Techatraisak K, Pratumvinit B, Sa-Nga-Areekul N.
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):499-506. PubMed ID: 30122568
    [Abstract] [Full Text] [Related]

  • 27. Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
    Lie Fong S, Schipper I, de Jong FH, Themmen AP, Visser JA, Laven JS.
    Fertil Steril; 2011 Aug; 96(2):459-63. PubMed ID: 21719005
    [Abstract] [Full Text] [Related]

  • 28. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
    Bell RJ, Islam RM, Skiba MA, Herbert D, Martinez Garcia A, Davis SR.
    Hum Reprod; 2021 Dec 27; 37(1):109-118. PubMed ID: 34741176
    [Abstract] [Full Text] [Related]

  • 29. Ovarian morphology in polycystic ovary syndrome: estimates from 2D and 3D ultrasound and magnetic resonance imaging and their correlation to anti-Müllerian hormone.
    Nylander M, Frøssing S, Bjerre AH, Chabanova E, Clausen HV, Faber J, Skouby SO.
    Acta Radiol; 2017 Aug 27; 58(8):997-1004. PubMed ID: 28273731
    [Abstract] [Full Text] [Related]

  • 30. Antimullerian hormone in cases of different reproductive pathologies.
    Barbakadze L, Kristasashvili J.
    Georgian Med News; 2014 Aug 27; (232-233):16-21. PubMed ID: 25214265
    [Abstract] [Full Text] [Related]

  • 31. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.
    Li J, Li R, Yu H, Zhao S, Yu Y, Qiao J.
    Syst Biol Reprod Med; 2015 Apr 27; 61(2):103-9. PubMed ID: 25329139
    [Abstract] [Full Text] [Related]

  • 32. The physiology and clinical utility of anti-Mullerian hormone in women.
    Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, Griesinger G, Kelsey TW, La Marca A, Lambalk C, Mason H, Nelson SM, Visser JA, Wallace WH, Anderson RA.
    Hum Reprod Update; 2014 Apr 27; 20(3):370-85. PubMed ID: 24430863
    [Abstract] [Full Text] [Related]

  • 33. Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value.
    Song DK, Oh JY, Lee H, Sung YA.
    Korean J Intern Med; 2017 Jul 27; 32(4):690-698. PubMed ID: 27899014
    [Abstract] [Full Text] [Related]

  • 34. Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials.
    Nelson SM, Klein BM, Arce JC.
    Fertil Steril; 2015 Apr 27; 103(4):923-930.e1. PubMed ID: 25624196
    [Abstract] [Full Text] [Related]

  • 35. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome.
    Pigny P, Jonard S, Robert Y, Dewailly D.
    J Clin Endocrinol Metab; 2006 Mar 27; 91(3):941-5. PubMed ID: 16368745
    [Abstract] [Full Text] [Related]

  • 36. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries.
    Dewailly D, Gronier H, Poncelet E, Robin G, Leroy M, Pigny P, Duhamel A, Catteau-Jonard S.
    Hum Reprod; 2011 Nov 27; 26(11):3123-9. PubMed ID: 21926054
    [Abstract] [Full Text] [Related]

  • 37. Relation of antimullerian hormone with the clinical signs of hyperandrogenism and polycystic ovary morphology.
    Sahmay S, Aydın Y, Atakul N, Aydogan B, Kaleli S.
    Gynecol Endocrinol; 2014 Feb 27; 30(2):130-4. PubMed ID: 24328568
    [Abstract] [Full Text] [Related]

  • 38. May AMH levels distinguish LOCAH from PCOS among hirsute women?
    Oncul M, Sahmay S, Tuten A, Acikgoz AS, Gurleyen HC.
    Eur J Obstet Gynecol Reprod Biol; 2014 Jul 27; 178():183-7. PubMed ID: 24792539
    [Abstract] [Full Text] [Related]

  • 39. Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained infertility.
    Greenwood EA, Cedars MI, Santoro N, Eisenberg E, Kao CN, Haisenleder DJ, Diamond MP, Huddleston HG, National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development Cooperative Reproductive Medicine Network.
    Fertil Steril; 2017 Dec 27; 108(6):1070-1077. PubMed ID: 29202959
    [Abstract] [Full Text] [Related]

  • 40. Comparative assessment of five serum antimüllerian hormone assays for the diagnosis of polycystic ovary syndrome.
    Pigny P, Gorisse E, Ghulam A, Robin G, Catteau-Jonard S, Duhamel A, Dewailly D.
    Fertil Steril; 2016 Apr 27; 105(4):1063-1069.e3. PubMed ID: 26769302
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 56.